These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity. Charmandari E; Kino T; Chrousos GP Endocr Dev; 2013; 24():67-85. PubMed ID: 23392096 [TBL] [Abstract][Full Text] [Related]
8. An unexpected, mild phenotype of glucocorticoid resistance associated with glucocorticoid receptor gene mutation case report and review of the literature. Molnár Á; Patócs A; Likó I; Nyírő G; Rácz K; Tóth M; Sármán B BMC Med Genet; 2018 Mar; 19(1):37. PubMed ID: 29510671 [TBL] [Abstract][Full Text] [Related]
9. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes. Charmandari E; Kino T Eur J Clin Invest; 2010 Oct; 40(10):932-42. PubMed ID: 20649902 [TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the glucocorticoid receptor gene as a cause of severe glucocorticoid resistance complicated by hypertensive encephalopathy. Tatsi C; Xekouki P; Nioti O; Bachrach B; Belyavskaya E; Lyssikatos C; Stratakis CA J Hypertens; 2019 Jul; 37(7):1475-1481. PubMed ID: 31145715 [TBL] [Abstract][Full Text] [Related]
13. Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1. Donner KM; Hiltunen TP; Jänne OA; Sane T; Kontula K Eur J Endocrinol; 2013 Jan; 168(1):K9-K18. PubMed ID: 23076843 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Glucocorticoid Signaling. Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454 [TBL] [Abstract][Full Text] [Related]
15. Bilateral adrenal hyperplasia and NR3C1 mutations causing glucocorticoid resistance: Is there an association? Nicolaides NC; Chrousos GP Eur J Endocrinol; 2018 Oct; 179(5):C1-C4. PubMed ID: 30006372 [TBL] [Abstract][Full Text] [Related]
16. Further characterization of human glucocorticoid receptor mutants, R477H and G679S, associated with primary generalized glucocorticoid resistance. Ruiz M; Hedman E; Gåfvels M; Eggertsen G; Werner S; Wahrenberg H; Wikström AC Scand J Clin Lab Invest; 2013 Apr; 73(3):203-7. PubMed ID: 23391271 [TBL] [Abstract][Full Text] [Related]
17. A novel point mutation in the DNA-binding domain (DBD) of the human glucocorticoid receptor causes primary generalized glucocorticoid resistance by disrupting the hydrophobic structure of its DBD. Roberts ML; Kino T; Nicolaides NC; Hurt DE; Katsantoni E; Sertedaki A; Komianou F; Kassiou K; Chrousos GP; Charmandari E J Clin Endocrinol Metab; 2013 Apr; 98(4):E790-5. PubMed ID: 23426617 [TBL] [Abstract][Full Text] [Related]
18. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities. Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153 [TBL] [Abstract][Full Text] [Related]
19. Novel causes of generalized glucocorticoid resistance. Charmandari E; Kino T Horm Metab Res; 2007 Jun; 39(6):445-50. PubMed ID: 17578762 [TBL] [Abstract][Full Text] [Related]
20. A novel mutation in the NR3C1 gene associated with reversible glucocorticoid resistance. Laulhé M; Kuhn E; Bouligand J; Amazit L; Perrot J; Lebigot E; Kamenickỷ P; Lombès M; Fagart J; Viengchareun S; Martinerie L Eur J Endocrinol; 2024 Mar; 190(4):284-295. PubMed ID: 38584335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]